Press Enter for full results

Quick Links

Browse By Peptide

Browse By Application

Library Categories

, functional medicine researcher, data analyst, peptide specialist

, functional medicine researcher, data analyst, peptide specialist , functional medicine researcher, data analyst, peptide specialist

Marcus Reid is a functional medicine researcher, data analyst, and peptide specialist, and one of the people who built MyPeptidePal. The platform exists in part because of the years he spent immersed in clinical literature, real-world protocols, and the kind of hands-on experimentation that most textbooks skip entirely. He is not a physician and does not pretend to be. What he is, is someone who has done the work to understand how these compounds actually function at a biological level, what the research actually says versus what the forums claim, and how to explain it in a way that makes sense to anyone willing to learn. At MPP, Marcus contributed to building the knowledge base, the protocol frameworks, and the research systems that power the platform. His work covers tissue repair, metabolic health, hormonal optimization, longevity, cognitive function, and cosmetic applications. When the science gets complicated, his job is to make it click.

Articles by , functional medicine researcher, data analyst, peptide specialist

6 Best Peptides for Restless Leg Syndrome

Restless Leg Syndrome sits at the early frontier of peptide research. No peptide has been clinically validated or FDA-approved specifically for RLS, and the two compounds most often discussed in peptide communities, BPC-157 and Selank, have zero direct RLS trial data. What does exist is a genuinely important scientific lead: CGRP, a neuropeptide involved in pain signaling, has been found dysregulated in RLS patients in human studies, and compounds targeting that pathway have produced measurable symptom relief in small clinical trials. This guide covers six peptides people are researching and discussing for RLS, ordered by how prominently each appears in the science and in real-world use, not as a ranking of one compound over another. The honest picture is that this field is early, evidence is thin across the board, and for most people managing RLS today, non-peptide approaches remain the better-established path.

Neuroprotection 12 min read

6 Best Peptides for Vertigo

Six peptides and peptide-adjacent therapies show up consistently when people research or discuss treating vertigo, ranging from anti-CGRP monoclonal antibodies with strong clinical trial data for the vestibular migraine subtype to research-only compounds like KPV and TB-500 whose use is almost entirely community-reported. The field is unusually fragmented because vertigo is a symptom with multiple distinct causes, and no single compound is relevant across all of them. The entries here are ordered by how prominently each appears in research and documented real-world use, not as a recommendation of one over another, and the right choice depends entirely on which type of vertigo is in play, something a personalized plan rather than a general guide is built to address.

Ear Hearing Health 10 min read

6 Best Peptides for Tinnitus

Six peptides are most commonly used or discussed for tinnitus in 2026, ranging from oxytocin, which has the only human pilot trial data of any peptide in this space, to ARA-290 and BPC-157, which drive the most active community discussion. No peptide has cleared a large controlled trial for tinnitus, and no drug of any kind is FDA-approved for the condition, so the entire field sits somewhere between mechanistically plausible and preliminarily studied. These compounds are ordered by how prominently each appears in research and real-world use, not ranked as one being better than another for any individual.

Ear Hearing Health 10 min read

7 Best Peptides for Neuroinflammation

Seven peptides come up most consistently when people research neuroinflammation in 2026: BPC-157, Semax, Selank, Cerebrolysin, VIP, GHK-Cu, and Thymosin Alpha-1. This guide covers each one in turn, explaining what it is, how people use it for neuroinflammation, and what the evidence honestly shows. The compounds are ordered by how prominently each appears in research and real-world use for this goal, not as a ranking of one being better than another. The evidence ranges from regional clinical trials to preclinical animal data to community-reported experience, and each entry states that honestly.

Neuroprotection 12 min read

5 Best Peptides for Trigeminal Neuralgia

Trigeminal neuralgia is one of the most severe pain conditions known, and people living with it are searching every corner of the treatment landscape for anything that helps. A small number of peptides have entered that conversation, some through off-label clinic protocols, some through community neuropathy forums, and at least two through formal FDA regulatory review for TN-related indications in July 2026. This guide covers five compounds that people actually use or are actively discussing for trigeminal neuralgia, ordered by how prominently each appears in research and real-world use, not as a ranking from best to worst. The evidence for every compound here is early, off-label, or experiential, and that is stated plainly for each one.

Pain Management 10 min read

5 Best Peptides for Bell's Palsy

Bell's Palsy is an acute facial nerve condition that most people recover from within weeks to months, but a meaningful subset want to support the regeneration process beyond standard corticosteroid treatment. A small field of peptides has emerged in that gap, ranging from Cerebrolysin, which carries adjunct clinical testing as a nerve recovery support, to research-stage and community-reported options like BPC-157, ARA-290, IGF-1, and the endogenous neuropeptide PACAP. No peptide has completed a randomized controlled trial specifically for Bell's Palsy as of 2026, so this is an honest but thin evidence landscape. The five compounds below are ordered by how prominently each appears in research and documented real-world use for this goal, not as a recommendation of one over another, and every entry states the evidence as it actually stands.

Neural Regeneration 9 min read

6 Best Peptides for ALS (Amyotrophic Lateral Sclerosis)

Six peptides come up most consistently when people research options for ALS, ranging from Cerebrolysin, a neurotrophic mixture with real European clinical use, to preclinical-only candidates like Colivelin and P21 that are followed closely in research-oriented patient communities. No peptide has been proven in human trials to slow or reverse ALS progression, and the honest state of the evidence for each compound below ranges from extrapolated animal data to limited real-world use. The entries are ordered by how prominently each appears in research and documented real-world use for ALS, not as a recommendation of one over another, and none of them are substitutes for specialist care.

Neurodegenerative Diseases 11 min read

5 Best Peptides for Huntington's Disease

Huntington's Disease occupies an unusual place in peptide research: several compounds have emerged as candidates through preclinical science and mechanistic reasoning, but none has completed human clinical trials, and the broader peptide community has not widely adopted HD as a routine protocol target the way it has for conditions like cognitive decline or joint repair. This guide covers the five peptides that researchers and informed observers are actually discussing for HD, from HD-specific experimental compounds like P42 to neuroprotective options like Cerebrolysin and Semax whose mechanisms overlap meaningfully with HD pathology. They are ordered by how prominently each appears in the research and in informed HD discussion, not ranked as recommendations, and the evidence across all five is honestly thin, preclinical for the HD-specific entries and entirely extrapolated for the neuroprotective ones.

Neurodegenerative Diseases 9 min read

7 Best Peptides for Epilepsy and Seizures

People researching peptides for epilepsy and seizures are working in one of the most experimental corners of peptide science. No peptide has received FDA approval for epilepsy as of 2026, and no compound in this space has completed a human clinical trial for seizure control. What does exist is a genuinely interesting body of preclinical research spanning several distinct mechanisms, from GABAergic enhancement and glutamate reduction to blood-brain barrier repair and neuroinflammation, alongside two nootropic peptides, Selank and Semax, that have animal model evidence for anticonvulsant activity and are discussed in research communities worldwide. This guide covers seven peptides that appear in published preclinical research and active discussion for this goal. They are ordered by how prominently each shows up in the research literature and in documented discussion, not as a recommendation of one compound over another.

Neuroprotection 12 min read

5 Best Peptides for Cluster Headaches

Cluster headaches have one of the most clearly mapped neuropeptide mechanisms in all of neurology, and the compounds people turn to for this condition range from galcanezumab, the only FDA-approved CGRP-targeting therapy with Phase III trial data, to research peptides like Semax and BPC-157 that appear on investigational lists without any cluster headache evidence at all. This guide covers five compounds across that full range, ordered by how prominently each appears in research and documented real-world use for cluster headaches, not ranked from best to worst. The honest shape of this field is that one compound has strong clinical standing, one has established off-label clinical use, and three are theoretical candidates whose connection to cluster headache biology remains unproven.

Pain Management 10 min read

7 Best Peptides for Headaches

People researching peptide options for headaches and migraines encounter two distinct conversations at once. The first is clinical: a class of FDA-approved CGRP-targeting therapies that represent the most evidence-backed peptide-pathway treatments available today. The second is community-driven: a set of research compounds including Semax, Selank, BPC-157, Ipamorelin, and GLP-1 receptor agonists that users report exploring with varying results, mostly without clinical trial support for their specific use in headaches. This guide covers all seven, ordered by how prominently each appears in research and real-world discussion rather than as a ranking of one over another, with every compound's evidence stated as honestly as the next.

Pain Management 11 min read

6 Best Peptides for Migraines

People searching for peptides to address migraines are working with an unusually wide field: the most clinically validated options are FDA-approved biologics that target a neuropeptide called CGRP, while the compounds most discussed in the research-peptide community, including BPC-157, Semax, Selank, and Ipamorelin, range from preclinical animal data to isolated user-reported accounts. This guide covers six compounds people actually use or are actively discussing for migraines, ordered by how prominently each appears in research and documented real-world use, not as a recommendation of one over another. The honest picture here varies more than in almost any other peptide goal, and understanding where each compound stands is the starting point for building a plan that fits your situation.

Pain Management 11 min read

5 Best Peptides for Sciatica

Five peptides have built real followings among people dealing with sciatica, from BPC-157, which has the deepest community use and promising animal research on nerve regeneration, to ARA-290, the only compound here with Phase II human trial data for neuropathic pain. This guide covers each one in the order they appear in research and real-world use, not as a ranking from best to worst, because the right compound depends on your situation. No human clinical trial has yet confirmed any peptide as a proven treatment for sciatica specifically, so the evidence picture for each entry is stated as plainly as possible.

Pain Management 10 min read

6 Best Peptides for Peripheral Nerve Injury

Peripheral nerve injury is one of the harder targets in regenerative medicine, and the peptides people reach for in this space reflect that difficulty. Six compounds come up consistently in research and community use: BPC-157 carries the deepest animal data for nerve repair, ARA-290 has the most developed clinical investigation record for neuropathic conditions, and Cerebrolysin brings decades of international clinical use behind it. The other three, TB-500, Semax, and Cortagen, each fill a distinct role in the protocols people are actually running. The compounds are ordered by how prominently each appears in research and real-world use, not ranked as recommendations. Evidence for each is stated honestly, because no peptide has completed a human clinical trial specifically for peripheral nerve injury as of mid-2026, and the entries make that clear without burying the genuinely useful preclinical and clinical adjacent data that exists.

Neural Regeneration 11 min read

6 Best Peptides for Nerve Pain

Six peptides come up consistently when people explore alternatives to conventional nerve pain treatment in 2026: BPC-157, TB-500, ARA 290, Cerebrolysin, Semax, and Cortagen. They range from compounds with strong animal model data and years of community use to compounds whose evidence is thin and whose following is small but real. The evidence behind each one is described honestly inside its entry rather than flattened into a single verdict. These are ordered by how prominently each appears in research and real-world use for nerve pain, not ranked as recommendations, because the right compound for any individual depends on their specific condition and circumstances, and that decision belongs in the MyPeptidePal app.

Pain Management 11 min read